Aflac (AFL) Competitors

67.4% of Aflac shares are held by institutional investors. Comparatively, 97.4% of AMERISAFE shares are held by institutional investors. 0.8% of Aflac shares are held by company insiders. Comparatively, 2.0% of AMERISAFE shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Aflac pays an annual dividend of $2.44 per share and has a dividend yield of 1.9%. AMERISAFE pays an annual dividend of $1.64 per share and has a dividend yield of 5.6%. Aflac pays out 27.7% of its earnings in the form of a dividend. AMERISAFE pays out 66.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Aflac has raised its dividend for 44 consecutive years and AMERISAFE has raised its dividend for 12 consecutive years.

Aflac presently has a consensus target price of $116.17, suggesting a potential downside of 8.91%. AMERISAFE has a consensus target price of $44.00, suggesting a potential upside of 51.52%. Given AMERISAFE's higher probable upside, analysts plainly believe AMERISAFE is more favorable than Aflac.

In the previous week, Aflac had 14 more articles in the media than AMERISAFE. MarketBeat recorded 25 mentions for Aflac and 11 mentions for AMERISAFE. Aflac's average media sentiment score of 1.19 beat AMERISAFE's score of 0.28 indicating that Aflac is being referred to more favorably in the media.

Aflac has a net margin of 25.60% compared to AMERISAFE's net margin of 14.00%. AMERISAFE's return on equity of 14.87% beat Aflac's return on equity.

Aflac has higher revenue and earnings than AMERISAFE. AMERISAFE is trading at a lower price-to-earnings ratio than Aflac, indicating that it is currently the more affordable of the two stocks.

Aflac has a beta of 0.6, indicating that its share price is 40% less volatile than the broader market. Comparatively, AMERISAFE has a beta of 0.24, indicating that its share price is 76% less volatile than the broader market.

Aflac has a net margin of 25.60% compared to Trupanion's net margin of 1.74%. Aflac's return on equity of 13.88% beat Trupanion's return on equity.

67.4% of Aflac shares are owned by institutional investors. 0.8% of Aflac shares are owned by company insiders. Comparatively, 5.6% of Trupanion shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Aflac has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market. Comparatively, Trupanion has a beta of 1.39, meaning that its stock price is 39% more volatile than the broader market.

Aflac has higher revenue and earnings than Trupanion. Aflac is trading at a lower price-to-earnings ratio than Trupanion, indicating that it is currently the more affordable of the two stocks.

Aflac presently has a consensus price target of $116.17, indicating a potential downside of 8.91%. Trupanion has a consensus price target of $41.60, indicating a potential upside of 69.87%. Given Trupanion's stronger consensus rating and higher probable upside, analysts plainly believe Trupanion is more favorable than Aflac.

In the previous week, Aflac had 19 more articles in the media than Trupanion. MarketBeat recorded 25 mentions for Aflac and 6 mentions for Trupanion. Aflac's average media sentiment score of 1.19 beat Trupanion's score of 1.03 indicating that Aflac is being referred to more favorably in the media.

Allstate has higher revenue and earnings than Aflac. Allstate is trading at a lower price-to-earnings ratio than Aflac, indicating that it is currently the more affordable of the two stocks.

Allstate pays an annual dividend of $4.32 per share and has a dividend yield of 1.6%. Aflac pays an annual dividend of $2.44 per share and has a dividend yield of 1.9%. Allstate pays out 9.5% of its earnings in the form of a dividend. Aflac pays out 27.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Allstate has increased its dividend for 15 consecutive years and Aflac has increased its dividend for 44 consecutive years. Aflac is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Aflac had 1 more articles in the media than Allstate. MarketBeat recorded 25 mentions for Aflac and 24 mentions for Allstate. Aflac's average media sentiment score of 1.19 beat Allstate's score of 1.16 indicating that Aflac is being referred to more favorably in the news media.

Aflac has a net margin of 25.60% compared to Allstate's net margin of 17.81%. Allstate's return on equity of 42.66% beat Aflac's return on equity.

Allstate currently has a consensus target price of $254.80, suggesting a potential downside of 3.68%. Aflac has a consensus target price of $116.17, suggesting a potential downside of 8.91%. Given Allstate's stronger consensus rating and higher possible upside, equities analysts plainly believe Allstate is more favorable than Aflac.

76.5% of Allstate shares are owned by institutional investors. Comparatively, 67.4% of Aflac shares are owned by institutional investors. 1.6% of Allstate shares are owned by insiders. Comparatively, 0.8% of Aflac shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Allstate has a beta of 0.16, meaning that its stock price is 84% less volatile than the broader market. Comparatively, Aflac has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market.

Aflac has a net margin of 25.60% compared to Employers' net margin of 0.91%. Aflac's return on equity of 13.88% beat Employers' return on equity.

Aflac has higher revenue and earnings than Employers. Aflac is trading at a lower price-to-earnings ratio than Employers, indicating that it is currently the more affordable of the two stocks.

Employers pays an annual dividend of $1.36 per share and has a dividend yield of 2.7%. Aflac pays an annual dividend of $2.44 per share and has a dividend yield of 1.9%. Employers pays out 197.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Aflac pays out 27.7% of its earnings in the form of a dividend. Employers has increased its dividend for 4 consecutive years and Aflac has increased its dividend for 44 consecutive years.

Employers has a beta of 0.47, meaning that its share price is 53% less volatile than the broader market. Comparatively, Aflac has a beta of 0.6, meaning that its share price is 40% less volatile than the broader market.

80.5% of Employers shares are owned by institutional investors. Comparatively, 67.4% of Aflac shares are owned by institutional investors. 1.3% of Employers shares are owned by insiders. Comparatively, 0.8% of Aflac shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Employers currently has a consensus target price of $59.00, indicating a potential upside of 16.91%. Aflac has a consensus target price of $116.17, indicating a potential downside of 8.91%. Given Employers' stronger consensus rating and higher possible upside, equities research analysts plainly believe Employers is more favorable than Aflac.

In the previous week, Aflac had 5 more articles in the media than Employers. MarketBeat recorded 25 mentions for Aflac and 20 mentions for Employers. Aflac's average media sentiment score of 1.19 beat Employers' score of 0.84 indicating that Aflac is being referred to more favorably in the news media.